发明授权
- 专利标题： Bladder cancer specific ligand peptides
- 专利标题（中）： 膀胱癌特异性配体肽
-
申请号： US13497041申请日： 2010-09-23
-
公开(公告)号： US08946379B2公开(公告)日： 2015-02-03
- 发明人: Chong-xian Pan , Hongyong Zhang , Kit S. Lam , Olulanu H. Aina
- 申请人： Chong-xian Pan , Hongyong Zhang , Kit S. Lam , Olulanu H. Aina
- 申请人地址： US CA Oakland
- 专利权人： The Regents of the University of California
- 当前专利权人： The Regents of the University of California
- 当前专利权人地址： US CA Oakland
- 代理机构： Weaver Austin Villeneuve & Sampson LLP
- 代理商 Jennifer L. Wahlsten
- 国际申请： PCT/US2010/050037 WO 20100923
- 国际公布： WO2011/038142 WO 20110331
- 主分类号： C07K5/00
- IPC分类号： C07K5/00 ; G01N33/574 ; A61K47/48 ; A61K49/00 ; B82Y5/00 ; C07K7/06 ; A61K38/00
摘要：
The present invention is directed to bladder cancer specific ligand peptides, comprising the amino acid sequence X1DGRX5GF (SEQ ID NO:1), and methods of their use, e.g., for imaging detection for diagnosis of bladder, tumor localization to guide transurethral resection of bladder cancer, imaging detection of bladder cancer for follow-up after the initial treatment that can replace or complement costly cystoscopy, imaging detection of metastatic bladder cancer, and targeted therapy for superficial and metastatic bladder cancer.
公开/授权文献
- US20120230994A1 BLADDER CANCER SPECIFIC LIGAND PEPTIDES 公开/授权日：2012-09-13
信息查询
